Product Details for: Tysabri

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
300MG/15ML (20MG/ML)
Single-Dose Vial
351(a)
Tysabri
Rx
Proper Name
natalizumab
BLA Number
125104
Applicant
Biogen Inc.
Original Approval Date
November 23, 2004
Date of First Licensure
Patent List Provided
Yes
RETURN TO SEARCH RESULTS